Navigation Links
Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics
Date:12/2/2008

property and corporate development. "For Intradigm, this patent becomes even more valuable when combined with the company's proprietary RNAi sequences and delivery technologies. Ultimately, access to this intellectual property will allow Intradigm to create a high value pipeline of well- protected products developed by incorporating novel, enhanced RNAi sequences into the company's innovative RNAi delivery systems."

Intradigm possesses one of the industry's strongest RNAi IP positions including key assets strategically licensed from both the University of Massachusetts Medical School and the Massachusetts Institute of Technology (MIT). The company's IP estate of issued patents and pending applications broadly covers structural features for a next generation of RNAi molecules, biodegradable polycationic polymers for the delivery of RNAi therapeutics, and proprietary siRNA sequence applications.

ABOUT INTRADIGM

Intradigm is a private biotechnology company committed to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases with an initial focus on oncology. Intradigm is unique, among private companies, with its comprehensive RNAi therapeutics platform consisting of structural features for next- generation of RNAi molecules, biodegradable polycationic polymers for the delivery of RNAi therapeutics and proprietary siRNA sequence applications. Our proprietary delivery technology is unique in its potential to offer safe and effective systemic administration using a library of novel peptide-based biodegradable polymers.

We have established an impressive proprietary portfolio of siRNA sequences against more than 50 highly valued oncology and other disease targets. In addition, we have secured an exclusive license to the Zamore patent family from the University of Massachusetts<
'/>"/>

SOURCE Intradigm Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
2. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
3. Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing
4. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
5. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
6. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
7. Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinsons Disease
8. Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria
9. Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference
10. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
11. Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Global HIV Infection Drug Market and ... Reportstack. The rate of HIV infection and the number of ... at a positive rate across the globe. It has been ... 2005 to 1.5 in 2013, with the rates for children ... changes in the infection rates has been the improved access ...
(Date:8/18/2014)... 2014 According to the ... Application (Municipal Wastewater Treatment and Industrial Wastewater Treatment), ... Tubular), By Configuration (Internal/Submerged and External/Sidestream), and By ... The market for membrane bioreactor systems is projected ... a CAGR of 15.28% between 2014 and 2019. ...
(Date:8/18/2014)... Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... Form 10 with the U.S. Securities and Exchange ... http://photos.prnewswire.com/prnh/20110621/CL06708LOGO The Form 10 ...
(Date:8/18/2014)... August 2014 Vier führende deutsche ... klinische Studie auf, in der eine Intraokularlinse ... das Sehvermögen bei allen Entfernungen verbessern, so ... keine Lese- oder Gleitsichtbrille mehr benötigen. Die ... FluidVision Accommodating Intraocular Lens (FluidVision akkomodative ...
Breaking Biology Technology:Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... along the Gulf Coast, so many people have volunteered time ... speed the recovery of this region. From afar, though, it's ... really making a difference. , ,Then, last week, I got ... Massachusetts, who decided to go to Houston where she could ...
... - Machine tool builder Mazak Corp. of ... Berlin-based Micro Estimating Systems Inc. for performing ... expanded National Technology Center. , ,Mazak plans to use ... Centers (Los Angeles, Houston, Atlanta, Chicago, and Hartford), networked ...
... faculty have created a new dual-degree graduate program in ... apply such knowledge to problems in public policy. , ... Clark Miller, a professor of science and technology policy ... "Or what about brain mechanisms that are responsible for ...
Cached Biology Technology:The DEMO / Katrina Challenge 2The DEMO / Katrina Challenge 3UW offers new program in neuroscience and public policy 2
(Date:8/20/2014)... Mo. A new gene therapy developed by researchers ... been shown to protect mice from a life-threatening heart ... a new therapeutic avenue," said Yi Lai, Ph.D., the ... in the MU School of Medicine,s Department of Molecular ... but we hope this could lead to a treatment ...
(Date:8/20/2014)... researchers have developed methods for electronically manipulating the flight ... moths use to control those muscles. The work opens ... "biobots," for use in emergency response. , "In the ... control the movement of moths for use in applications ... Bozkurt, an assistant professor of electrical and computer engineering ...
(Date:8/20/2014)... YORK and POINT ROBERTS, Washington ... Biometrics Play a Key Role in Addressing Security Concerns in ... ), a global news source covering leading sectors including biometrics, ... wallet market. Jason Peaslee , Managing Partner ... Institute and Gino Pereira , CEO of NXT-ID, Inc. ...
Breaking Biology News(10 mins):Gene therapy protects mice from lethal heart condition, MU researchers find 2Research paves way for development of cyborg moth 'biobots' 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7
... nerve cells, communicate with each other through contact points ... down, causing the messages that would normally help our ... our car keys to fall short. Now scientists ... School of Medicine have shown that a protein called ...
... that Epinephilus maculates, a fairly abundant species of grouper ... microscopic monogenean worms. This diversity of parasites has just ... another the coral reef species. If such a level ... of thousands of parasite species are in this ecosystem ...
... be to blame for the gradual extinction of cold-loving ... to Ulrich Kutschera and colleagues from the University of ... Austria. Their findings show that human-induced temperature increases ... Austria may have led to the near extinction of ...
Cached Biology News:Specific brain protein required for nerve cell connections to form and function 2Coral reef fish harbor an unexpectedly high biodiversity of parasites 2Coral reef fish harbor an unexpectedly high biodiversity of parasites 3Role reversal as humans suck life out of leeches 2
... offers single pass sequencing of plasmids ... fueled by our high performance sequencing ... Phred20 bases per day. The key ... sequencing customers are rapid turnaround, high ...
... Agencourt offers quick turnaround sequencing of ... copy and high copy plasmids. Agencourt's world-class, ... million Phred20 bases per day. The ... Sequencing service are 24 48 hour ...
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
Biology Products: